Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.99 -0.19 (-1.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Change in Account Payables (2026)

Updated

Zevra Therapeutics (ZVRA) reported Change in Account Payables of -$500,000 for Q2 2026.

Analysis

Zevra Therapeutics (ZVRA) Change in Account Payables (2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Zevra Therapeutics' Change in Account Payables came in at -$4.89 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Zevra Therapeutics 592.83 Mn -219.88 Mn 38.18 Mn -500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -500,000.00
Mar 31, 2026 -4.39 Mn
API Access

Zevra Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=ZVRA&period=max&api_key=YOUR_API_KEY